Top Scoops

Book Reviews | Gordon Campbell | Scoop News | Wellington Scoop | Community Scoop | Search

 

Government Must Promise NZ Won’t Cave On Pharmac In TPPA

7 February 2013

For immediate release

Government Must Promise NZ Won’t Cave On Pharmac In TPPA

‘The government needs to come clean on whether it plans to cave in to US demands on medicines in the Trans-Pacific Partnership Agreement (TPPA), due to reconvene in Singapore in early March’, says Professor Jane Kelsey who monitors the negotiations.

Last November Trade Minister Tim Groser signalled to the Americans that New Zealand was willing to be ‘flexible’ on new disciplines for Pharmac.

This could mean one of two things. New Zealand would either concede to US demands in the intellectual property chapter, especially pharmaceutical patents, or to the rights of Big Phrma and its local branch to have a stronger say in Pharmac’s decision-making process in the name of ‘transparency’.

It seemed pretty clear from the Minister’s statement in late November that the Cabinet had already made a decision, in secret, or was about to do so.

‘This makes no sense, given the government’s insistence that it requires genuine and substantial concessions on dairy market access to the US. The American chief negotiator reported after the Auckland round that they haven’t had any serious talks about dairy with New Zealand and are in no hurry to do so.’

Professor Kelsey noted that ‘the stakes are huge. PHARMAC's latest annual report shows it has saved the New Zealand taxpayer $5 billion over the past 12 years and expanded access to medicines while staying within budget.’

‘Giving up the fight on patents, for example, would hike up the price of medicines significantly, especially if it impacts on access to much cheaper generics’.

Professor Kelsey challenged the government to state publicly that it is not planning to give way on Pharmac in either respect, ahead of the next round in Singapore.

‘Once a concession is tabled it would be almost impossible to withdraw’.

‘The public health community should be up in arms about the imminent prospect of such a behind-closed-doors assault on affordable medicines. The Labour Party has said Pharmac is a red line. It is time it put the government on the mat to get assurances that it will not table a position that gives way on either patents or transparency.’

ENDS

© Scoop Media

 
 
 
Top Scoops Headlines

 

Fatuous Defence: Australia’s Guided Missile Plans

Even in times of pandemic crises, some things never change. While Australia gurgles and bumbles slowly with its COVID-19 vaccine rollout, there are other priorities at stake. Threat inflators are receiving much interest in defence, and the media ... More>>

Richard S. Ehrlich: Cambodia's Hun Sen Feels Politically Vaccinated

BANGKOK, Thailand -- When Cambodian Prime Minister Hun Sen received his AstraZeneca vaccination shot, he suddenly felt invulnerable and vowed to rule indefinitely. Hun Sen is already one of the world's longest ruling prime ministers, confident his successor ... More>>

Reese Erlich: Foreign Correspondent: My Final Column?

I’m dying. It’s not easy to write these words. But it’s true. More>>

Binoy Kampmark: Brawling Over Vaccines: Export Bans And The EU’s Bungled Rollout
The European Union has been keeping up appearances in encouraging the equitable distribution of vaccines to combat SARS-CoV-2 and its disease, COVID-19. Numerous statements speak to the need to back the COVAX scheme, to ensure equity and that no one state misses out... More>>

Jennifer S. Hunt: Trump Evades Conviction Again As Republicans Opt For Self-Preservation

By Jennifer S. Hunt Lecturer in Security Studies, Australian National University Twice-impeached former US President Donald Trump has evaded conviction once more. On the fourth day of the impeachment trial, the Senate verdict is in . Voting guilty: ... More>>

Binoy Kampmark: Let The Investigation Begin: The International Criminal Court, Israel And The Palestinian Territories

International tribunals tend to be praised, in principle, by those they avoid investigating. Once interest shifts to those parties, such bodies become the subject of accusations: bias, politicisation, crude arbitrariness. The United States, whose legal and political ... More>>